Simon Quick Advisors LLC Acquires Shares of 2,267 Masimo Corporation $MASI

Simon Quick Advisors LLC purchased a new stake in Masimo Corporation (NASDAQ:MASI) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,267 shares of the medical equipment provider’s stock, valued at approximately $381,000.

A number of other large investors also recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 66 shares during the period. Assetmark Inc. raised its stake in Masimo by 5.0% during the 2nd quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider’s stock worth $259,000 after buying an additional 73 shares during the period. Xponance Inc. raised its stake in Masimo by 1.1% during the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider’s stock worth $1,183,000 after buying an additional 76 shares during the period. Deutsche Bank AG raised its stake in Masimo by 1.5% during the 1st quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider’s stock worth $1,051,000 after buying an additional 92 shares during the period. Finally, State of Michigan Retirement System raised its stake in Masimo by 1.0% during the 1st quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider’s stock worth $1,765,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Insider Buying and Selling at Masimo

In other Masimo news, Director William R. Jellison purchased 3,000 shares of the company’s stock in a transaction dated Monday, August 11th. The stock was bought at an average cost of $145.98 per share, for a total transaction of $437,940.00. Following the completion of the transaction, the director owned 4,790 shares in the company, valued at approximately $699,244.20. This represents a 167.60% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Insiders own 9.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on MASI. Zacks Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. BTIG Research reissued a “buy” rating and issued a $198.00 price target on shares of Masimo in a research note on Thursday, September 11th. Piper Sandler lifted their price target on Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 6th. Finally, Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Masimo presently has a consensus rating of “Moderate Buy” and an average target price of $194.60.

Masimo Trading Down 0.6%

Masimo stock opened at $140.65 on Monday. Masimo Corporation has a 52 week low of $133.70 and a 52 week high of $194.88. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The stock has a market capitalization of $7.64 billion, a P/E ratio of -16.51 and a beta of 1.28. The stock has a 50-day simple moving average of $144.80 and a 200 day simple moving average of $154.12.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 EPS for the quarter. The business had revenue of $617.00 million during the quarter. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%. Analysts expect that Masimo Corporation will post 4.1 earnings per share for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.